Successful pembrolizumab treatment in a patient with metastatic urothelial carcinoma and underlying overlap syndrome involving systemic sclerosis and systemic lupus erythematosus

Successful pembrolizumab treatment in a patient with metastatic urothelial carcinoma and underlying overlap syndrome involving systemic sclerosis and systemic lupus erythematosus

Introduction The safety and efficacy of pembrolizumab administration in patients with urothelial carcinoma and underlying autoimmune disease (including overlap syndrome) is unknown. Case presentation We present the case of a 67‐year‐old woman with cT3N2M0 metastatic renal pelvic cancer who had been...

Full description

Bibliographic Details
Main Authors: Masayuki Kurokawa, Sei Naito, Suguru Ito, Satoshi Takai, Yuko Kawamura, Hisashi Kaneko, Hiroshi Kakizaki, Norihiko Tsuchiya
Format: Article
Language:English
Published: Wiley 2020-09-01
Series:IJU Case Reports
Subjects:
autoimmune disease
metastatic urothelial carcinoma
overlap syndrome
pembrolizumab
renal pelvic cancer
Online Access:https://doi.org/10.1002/iju5.12175

Internet

https://doi.org/10.1002/iju5.12175

Similar Items